Skip to main content
Clinical Trials/KCT0007317
KCT0007317
Completed
未知

Verification of symptom improvement effect in elderly people with cognitive decline through inhalation of phytocide.

Hallym University Medical Center- Chuncheon0 sites68 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Mental and behavioural disorders
Sponsor
Hallym University Medical Center- Chuncheon
Enrollment
68
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 1, 2022
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Hallym University Medical Center- Chuncheon

Eligibility Criteria

Inclusion Criteria

  • 1\) Adults over 55 years of age.
  • 2\) Those who meet the diagnostic criteria for mild cognitive impairment or early Alzheimer's dementia.
  • (CDR 0\.5\-2 or GDS 2\-5, and memory complaint, normal activities of daily living, normal general cognitive function, abnormal memory for age and, not demented patients with mild cognitive impairment or Alzheimer's disease)
  • 3\) A patient who can read and understand the subject's explanation and consent form, and is capable of language skills at a level that can respond to questionnaires.
  • 4\) A patient who has voluntarily decided to participate in this clinical trial and who has consented in writing to the informed consent form and can participate in the entire clinical trial period.

Exclusion Criteria

  • (1\) Persons diagnosed with bipolar or psychotic major depressive disorder.
  • (2\) Persons with a history of uniaxial psychiatric disorders including intellectual disability, schizophrenia, alcoholism, and bipolar disorder.
  • (3\) Stroke, convulsive disease, Parkinson's disease, multiple sclerosis, cerebral palsy, Huntington's disease, encephalitis, meningitis, liver disease beyond cirrhosis, kidney disease to the extent of requiring dialysis, etc. that may interfere with completion of this cognitive training program; patient with medical condition.
  • (4\) Those with a history of convulsions.
  • (5\) Those who have found other neurological abnormalities that may cause memory impairment during medical examination.
  • (6\) When it is judged that there is a problem in attaching EEG and DC stimulation electrodes due to scalp deformity, inflammatory reaction, or other dermatological problems.
  • (7\) Those who have had cancer in the past 3 years.
  • (8\) Those who have undergone cerebrovascular surgery, such as brain surgery or carotid artery surgery.
  • (9\) Persons who have abused drugs in the past 5 years.

Outcomes

Primary Outcomes

Not specified

Similar Trials